Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1222

1.

A review of pharmacologic treatments for obsessive-compulsive disorder.

Kaplan A, Hollander E.

Psychiatr Serv. 2003 Aug;54(8):1111-8. Review.

PMID:
12883138
[PubMed - indexed for MEDLINE]
2.

Pharmacologic therapy of obsessive compulsive disorder.

DeVeaugh-Geiss J.

Adv Pharmacol. 1994;30:35-52. Review.

PMID:
7833296
[PubMed - indexed for MEDLINE]
3.

Combination treatment with clomipramine and selective serotonin reuptake inhibitors for obsessive-compulsive disorder in children and adolescents.

Figueroa Y, Rosenberg DR, Birmaher B, Keshavan MS.

J Child Adolesc Psychopharmacol. 1998;8(1):61-7.

PMID:
9639080
[PubMed - indexed for MEDLINE]
4.

Sertraline and obsessive compulsive disorder: new indication. Limited assessment.

[No authors listed]

Prescrire Int. 2000 Aug;9(48):112-3.

PMID:
11067720
[PubMed - indexed for MEDLINE]
5.

Serotonergic antidepressants and their efficacy in obsessive compulsive disorder.

Dominguez RA.

J Clin Psychiatry. 1992 Oct;53 Suppl:56-9. Review.

PMID:
1429485
[PubMed - indexed for MEDLINE]
6.

Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):163-5.

PMID:
15499694
[PubMed - indexed for MEDLINE]
7.

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.

Piccinelli M, Pini S, Bellantuono C, Wilkinson G.

Br J Psychiatry. 1995 Apr;166(4):424-43.

PMID:
7795913
[PubMed - indexed for MEDLINE]
8.

WCA recommendations for the long-term treatment of obsessive-compulsive disorder in adults.

Greist JH, Bandelow B, Hollander E, Marazziti D, Montgomery SA, Nutt DJ, Okasha A, Swinson RP, Zohar J; World Council of Anxiety.

CNS Spectr. 2003 Aug;8(8 Suppl 1):7-16. Review.

PMID:
14767394
[PubMed - indexed for MEDLINE]
9.

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.

Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH.

Am J Psychiatry. 1997 Sep;154(9):1293-5.

PMID:
9286191
[PubMed - indexed for MEDLINE]
10.

Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Dell'Osso B, Nestadt G, Allen A, Hollander E.

J Clin Psychiatry. 2006 Apr;67(4):600-10. Review.

PMID:
16669725
[PubMed - indexed for MEDLINE]
11.

Pharmacologic management of obsessive-compulsive disorder.

Jackson CW, Morton WA, Lydiard RB.

South Med J. 1994 Mar;87(3):310-21.

PMID:
8134850
[PubMed - indexed for MEDLINE]
12.

Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.

Fineberg NA, Pampaloni I, Pallanti S, Ipser J, Stein DJ.

Int Clin Psychopharmacol. 2007 Nov;22(6):313-22. Review.

PMID:
17917549
[PubMed - indexed for MEDLINE]
13.

A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.

Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB.

Int Clin Psychopharmacol. 1997 May;12(3):131-6.

PMID:
9248868
[PubMed - indexed for MEDLINE]
14.

Double-blind comparison of fluoxetine versus clomipramine in the treatment of obsessive compulsive disorder.

López-Ibor JJ Jr, Saiz J, Cottraux J, Note I, Viñas R, Bourgeois M, Hernández M, Gómez-Pérez JC.

Eur Neuropsychopharmacol. 1996 May;6(2):111-8.

PMID:
8791036
[PubMed - indexed for MEDLINE]
15.

Pharmacotherapy for obsessive-compulsive disorder.

Hollander E, Kaplan A, Allen A, Cartwright C.

Psychiatr Clin North Am. 2000 Sep;23(3):643-56. Review.

PMID:
10986733
[PubMed - indexed for MEDLINE]
16.

Evidence-based pharmacotherapy of obsessive-compulsive disorder.

Fineberg NA, Gale TM.

Int J Neuropsychopharmacol. 2005 Mar;8(1):107-29. Epub 2004 Sep 28. Review.

PMID:
15450126
[PubMed - indexed for MEDLINE]
17.

Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

Tundo A, Salvati L, Busto G, Di Spigno D, Falcini R.

J Clin Psychiatry. 2007 Oct;68(10):1552-6.

PMID:
17960971
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.

Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC.

Arch Gen Psychiatry. 1995 Jan;52(1):53-60.

PMID:
7811162
[PubMed - indexed for MEDLINE]
19.

[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].

Etain B, Bonnet-Perrin E.

Encephale. 2001 May-Jun;27(3):280-9. Review. French.

PMID:
11488259
[PubMed - indexed for MEDLINE]
20.

Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.

Flament MF, Bisserbe JC.

J Clin Psychiatry. 1997;58 Suppl 12:18-22. Review.

PMID:
9393392
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk